相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
A. D. Dobrian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic β-cell destruction induced by encephalomyocarditis virus
Hiroyuki Sano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression
Abdulqader A. Alhaider et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice
Tatsuhito Himeno et al.
DIABETES (2011)
Effect of Exenatide on Inflammatory and Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus
Jin-dan Wu et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M. A. Nauck et al.
DIABETOLOGIA (2011)
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
A. E. Hogan et al.
DIABETOLOGIA (2011)
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
R. Kodera et al.
DIABETOLOGIA (2011)
Protective effect of recombinant human glucagon-like peptide-1 (rhGLP-1) pretreatment in STZ-induced diabetic mice
Ye-Lin Wu et al.
JOURNAL OF PEPTIDE SCIENCE (2011)
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Masayuki Arakawa et al.
DIABETES (2010)
Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis
R. Fan et al.
DIABETES OBESITY & METABOLISM (2010)
Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients
U. Pugazhenthi et al.
DIABETOLOGIA (2010)
Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor
Lei Tian et al.
ENDOCRINOLOGY (2010)
GLP-1 Receptor Stimulation Reduces Amyloid-beta Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
Yazhou Li et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Hyun Woo Jeong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Diabetes Mellitus Activates Signal Transduction Pathways Resulting in Vascular Endothelial Growth Factor Resistance of Human Monocytes
Vadim Tchaikovski et al.
CIRCULATION (2009)
The anti-interleukin-1 in type 1 diabetes action trial - background and rationale
Linda M. S. Pickersgill et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
IL-1β-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells
M. L. B. Jacobsen et al.
DIABETOLOGIA (2009)
Islet-associated macrophages in type 2 diabetes
S. J. Richardson et al.
DIABETOLOGIA (2009)
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Marc Y. Donath et al.
PHYSIOLOGY (2009)
Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo
M. Kanitkar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Exendin-4 modulates diabetes onset in nonobese diabetic mice
Irene Hadjiyanni et al.
ENDOCRINOLOGY (2008)
Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: Implication for Th17 lymphocytes-mediated allergic inflammation
Phyllis F. Y. Cheung et al.
JOURNAL OF IMMUNOLOGY (2008)
Intracellular JNK, p38 MAPK and NF-KB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes
Chun Kwok Wong et al.
IMMUNOLOGY LETTERS (2007)
ERK implication in cell cycle regulation
Jean-Claude Chambard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
Cheol Whee Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Interleukin-25-induced chemokines and interleukin-6 from eosinophils in mediated by p38 mitogen-activated protein kinase, c-jun N-terminal kinase, and nuclear factor-κB
CK Wong et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B
L Li et al.
DIABETOLOGIA (2005)
Role of p38 MAPK and NF-kappa B for chemokine release in coculture of human eosinophils and bronchial epithelial cells
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
JC Pickup
DIABETES CARE (2004)
β-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes
RP Robertson et al.
DIABETES (2004)
Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes
MA Nauck et al.
DIABETES (2004)
Endoplasmic reticulum stress and the development of diabetes - A review
HP Harding et al.
DIABETES (2002)
A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis
DL Eizirik et al.
DIABETOLOGIA (2001)
Chemokines in pathology and medicine
M Baggiolini
JOURNAL OF INTERNAL MEDICINE (2001)
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
JC Pickup et al.
LIFE SCIENCES (2000)
分享论文
